FDA sends J & J another letter


Johnson and Johnson seems to be having their troubles with the Food and Drug Administration. First they received a Warning Letter for their oversight of clinical trials (see previous post). Now they are accused of false advertising for their Ertaczo cream to fight athletes foot and jock itch. J&J’s scientific ads said the product would “Crush, Kill, Destroy” the offending fungus. Of all the things to get nailed for.

According to Forbes.com:

“In an Aug. 21 letter released by the FDA Wednesday, the agency said the journal advertisement broadens the approved indication, contains unsubstantiated effectiveness claims about the product, and omits important risk information. Also, the FDA said J&J failed to submit the journal advertisement under current FDA regulations.”

And how is their stock doing? They seem to be shrugging it off. It’s down 0.23%.

GxP Perspectives LinkedIn Group

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out / Change )

Twitter picture

You are commenting using your Twitter account. Log Out / Change )

Facebook photo

You are commenting using your Facebook account. Log Out / Change )

Google+ photo

You are commenting using your Google+ account. Log Out / Change )

Connecting to %s

%d bloggers like this: